Back to results
US 12,589,158 B2Granted
GLP-1/GIP dual agonist, preparation method and use thereof
AssigneeHangzhou Zhongmeihuadong Pharmaceutical Co., Ltd.
InventorsNan Zhang, Chunhua Jiang, Dongzhou Liu, Li Teng, Jiale Shen
Life of this patent
Estimating the term…
Abstract
The present invention relates to long-acting GLP-1/GIP dual agonist compounds having a dual agonistic effect on glucagon-like peptide-1 (GLP-1) receptor and human glucose-dependent insulinotropic polypeptide (GIP) receptor. The present invention also relates to the use of said compounds in the manufacture of medicaments for treating Type II diabetes mellitus.
Claims2
A compound selected from the group consisting of:
- the compound of SEQ ID NO:5, in which K at position 24 is chemically modified through conjugation to the ε-amino of the K side-chain with ([2-(2-amino-ethoxy)-ethoxy]-acetyl)2-(γ-Glu)1-CO—(CH2)20—CO2H;
- and the C-terminal amino acid is amidated as a C-terminal primary amide;
- and
- the compound of SEQ ID NO:7, in which the K at position 24 is chemically modified through conjugation to the ε-amino of the K side-chain with ([2-(2-amino-ethoxy)-ethoxy]-acetyl)3-(γ-Glu)1-CO—(CH2)20—CO2H;
- and the C-terminal amino acid is amidated as a C-terminal primary amide.
2 more elements
Dependencies are inferred from the claim text.